Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 4Anovulation 2Thyroid Cancer, Papillary 1Infertility 1Hyperandrogenism 1Adenocarcinoma, Follicular 1

Interventions

Clomiphene 22Metformin 14Letrozole 12cetrorelix 6Triptorelin Pamoate 6Inositol 6Menotropins 5follitropin alfa 4Folic Acid 4Chorionic Gonadotropin 4Sperm Injections, Intracytoplasmic 3Medroxyprogesterone Acetate 3ulipristal acetate 2follitropin beta 2Uterine Myomectomy 2Therapeutics 2Tamoxifen 2Sugars 2Psychiatric Rehabilitation 2Progestins 2Liraglutide 2Lactalbumin 2Goserelin 2Gonadotropins 2Flutamide 2Fertilization in Vitro 2Dydrogesterone 2Cyclophosphamide 2Counseling 2testosterone undecanoate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Infertility × Glycoprotein Hormones, alpha Subunit × Clear all
NCT01081626 2014-02-13

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

Merck KGaA, Darmstadt, Germany

Phase 4 Completed
310 enrolled 18 charts

Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡